Respiratory syncytial virus infection induces heterologous protection against SARS-CoV-2 through γδ T cell-mediated trained immunity and the activation of SARS-CoV-2–reactive mucosal T cells
Journal of Virology · 21.04.2026 · 100 (4)
DOI: 10.1128/jvi.01658-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, erschienen am 21.04.2026. Verfasst von Awadalkareem Adam und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, SARS-CoV-2, COVID-19, Receptors, Antigen, T-Cell, gamma-delta. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NINDS NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Respiratory viruses can infect hosts concurrently or sequentially, potentially influencing each other’s pathogenic trajectory. However, the underlying immune mechanisms governing these interactions remain poorly understood. In this study, we examined whether respiratory syncytial virus (RSV) infection modulates host susceptibility to subsequent SARS-CoV-2 infection using two murine models. We found that prior RSV infection conferred dose- and time-dependent heterologous protection against SARS-CoV-2. Transcriptomic and immunological analyses revealed that RSV activated lung antigen-presenting cells (APCs) and SARS-CoV-2–reactive mucosal T cells by day 9 post-infection, with responses waning by 1 month. RSV also promoted expansion of pulmonary γδ T cells and upregulation of their metabolic pathways. Notably, RSV-infected TCRδ⁻ / ⁻ mice, which lack γδ T cells, exhibited diminished SARS-CoV-2–reactive mucosal T cell responses, elevated viral loads, and exacerbated lung inflammation following SARS-CoV-2 challenge compared to wild-type controls. These findings suggest that RSV infection induces γδ T cell-mediated trained immunity and primes mucosal T cell responses, thereby providing heterologous protection against SARS-CoV-2. IMPORTANCE The mechanisms by which prior respiratory viral infections confer heterologous protection remain largely undefined. In this study, we investigated whether respiratory syncytial virus (RSV) infection influences host susceptibility to subsequent SARS-CoV-2 infection in mice. We found that prior RSV exposure conferred dose- and time-dependent heterologous protection against SARS-CoV-2. Mechanistically, RSV infection induces γδ T cell-mediated trained immunity, enhances antigen-presenting cell activation, and promotes the generation of SARS-CoV-2–reactive mucosal T cells. Together, these immune responses contribute to cross-protective immunity against SARS-CoV-2. Our findings offer new insights into the immunological interplay between co-circulating respiratory viruses and SARS-CoV-2, with implications for future vaccine design and pandemic preparedness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
- Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, Texas, USA.
- Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
- Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.
- Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA.
- Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
ORCID-Profile: Parimal Samir, Tian Wang
Förderung
- NIAID NIH HHS
- NINDS NIH HHS
- NIA NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
- American Lung Association
- University of Texas Medical Branch
Zitieren
APA
Adam, A., Wu, W., Jones, M. C., Hao, H., Aditi, Samir, P., Bao, X., & Wang, T. (2026). Respiratory syncytial virus infection induces heterologous protection against SARS-CoV-2 through γδ T cell-mediated trained immunity and the activation of SARS-CoV-2–reactive mucosal T cells. Journal of Virology, 100(4). https://doi.org/10.1128/jvi.01658-25
Vancouver
Adam A, Wu W, Jones MC, Hao H, Aditi, Samir P, et al. Respiratory syncytial virus infection induces heterologous protection against SARS-CoV-2 through γδ T cell-mediated trained immunity and the activation of SARS-CoV-2–reactive mucosal T cells. Journal of Virology. 2026;100(4). doi:10.1128/jvi.01658-25
BibTeX
@article{Adam2026,
author = {Adam, Awadalkareem and Wu, Wenzhe and Jones, Madison C and Hao, Haiping and Aditi and Samir, Parimal and Bao, Xiaoyong and Wang, Tian},
title = {Respiratory syncytial virus infection induces heterologous protection against SARS-CoV-2 through γδ T cell-mediated trained immunity and the activation of SARS-CoV-2–reactive mucosal T cells},
journal = {Journal of Virology},
year = {2026},
volume = {100},
number = {4},
doi = {10.1128/jvi.01658-25}
}
EUVIMED